SECsense Logo

Quoin Pharmaceuticals Ltd. 8-K Report: Insights & SEC Compliance as of January 2025

$QNRX
Form 8-K
Filed on: 2025-01-06
Source
Quoin Pharmaceuticals Ltd. 8-K Report: Insights & SEC Compliance as of January 2025

Based on the provided section of the financial report, here are the key pieces of information and insights extracted:

  1. Entity Identification:
  • Company Name: Quoin Pharmaceuticals Ltd.
  • CIK (Central Index Key): 0001671502
  • IRS Employer Identification Number: 92-2593104
  • Address: 42127 Pleasant Forest Court, Ashburn, VA 20148-7349
  • Contact Number: 703-980-4182
  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: January 6, 2025
  1. Securities Information:
  • Securities Type: American Depositary Shares (ADS)
  • Representation: Each ADS represents one (1) Ordinary Share with no par value.
  • Exchange Listing: The ADS is listed on NASDAQ under the ticker symbol QNRX.
  1. Reporting Period:
  • As of Date: January 6, 2025
  1. Units of Measure:
  • Currency: USD (United States Dollar)
  • Shares: The report includes information about shares, likely in relation to the ADS.

Insights:

  • The filing indicates that Quoin Pharmaceuticals is actively reporting to the SEC, which suggests compliance with regulatory requirements.
  • The designation of American Depositary Shares indicates that the company is engaged in international markets and is likely seeking to attract investment from U.S. investors.
  • The presence of detailed contact information and the structured format of the filing suggests a focus on transparency and investor relations.

This information is crucial for investors, analysts, and stakeholders who are looking to evaluate the company's current status, compliance with SEC regulations, and potential investment opportunities.